Skip to main content
Clinical Trials/NCT06642779
NCT06642779CompletedNot Applicable

Comparative Analysis of the Visual Performance and Patient Satisfaction After Cataract Surgery With Implantation of a Medicontur Monofocal (877PAY) or a Medicontur Extended Depth of Focus (877PEY) IOL

Medicontur Medical Engineering Ltd3 sites in 1 country64 target enrollmentStarted: December 2, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
64
Locations
3
Primary Endpoint
DCIVA

Study Overview

Brief Summary

The purpose of this multi-center, prospective, randomized, comparative clinical investigation was to evaluate and compare the visual performance at far, intermediate and near distances, the presence of photopic phenomena and patient satisfaction after cataract surgery in patients implanted binocularly with a Medicontur monofocal (877PAY) or a Medicontur extended depth of focus (877PEY) IOL models.

The visit schedule included a total of 6 visits, in addition to the IOL implantation surgery, with the listed follow-up timeline:

  • screening and baseline assessments
  • day 0 (IOL implantation surgery)
  • day 1
  • month 1
  • month 3
  • month 6
  • month 12

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • cataractous patients who wish to be partly spectacle independent
  • cataractous lens changes as demonstrated by best corrected visual acuity of 20/40 or worse either with or without a glare source present (e.g., Brightness Acuity Tester) or with significant cataract-related visual symptoms*
  • best corrected visual acuity to be better than 20/25 (0.1 logMAR) after cataract removal and IOL implantation*
  • ≤ 1.0 D of preoperative keratometric astigmatism;
  • clear intraocular media other than cataract;
  • given written informed consent by subject;
  • subjects are willing and able to comply with schedule for follow-up visits;
  • adult patient

Exclusion Criteria

  • corneal astigmatism > 1.00 D
  • irregular astigmatism
  • diabetic retinopathy
  • iris neovascularisation
  • serious intraoperative complications
  • congenital eye abnormality
  • uncontrolled glaucoma or glaucoma with changes in optical nerve and visual field
  • pseudoexfoliation syndrome
  • amblyopia
  • long-term anti-inflammatory treatment
  • retinal detachment
  • prior ocular surgery in personal medical history
  • corneal diseases
  • severe retinal diseases (dystrophy, degeneration)
  • severe myopia (if required IOL power is lower than 10 D)
  • inadequate visualization of the fundus on preoperative examination
  • patients deemed by the clinical investigator because of any systemic disease.
  • eye trauma in medical history
  • Intraoperative exclusion criteria:
  • tear in capsulorhexis*
  • zonular dehiscence*
  • posterior capsular rupture vitreous loss and other unexpected surgical complication*
  • According to coordinator investigator's decision, the marked inclusion and exclusion criteria were not applied.

Outcomes

Primary Outcomes

DCIVA

Time Frame: measured at month 1, month 3, month 6 and month 12

distance corrected intermediate visual acuity

Secondary Outcomes

  • UDVA/CDVA(measured at month 1, month 3, month 6 and month 12)
  • VADC(measured at month 3, month 6 and month 12)
  • CSDC(measured at month 6 and month 12)
  • Patient satisfaction(Evaluated at month 3 and month 12)
  • CSV-1000(measured at month 3, month 6 and month 12)

Investigators

Sponsor
Medicontur Medical Engineering Ltd
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials